Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2019-09-10 2019-04-15
Drug Identification Number 02292270 02292270
Brand name CEFTRIAXONE SODIUM FOR INJECTION BP CEFTRIAXONE SODIUM FOR INJECTION BP
Common or Proper name CEFTRIAXONE CEFTRIAXONE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CEFTRIAXONE CEFTRIAXONE
Strength(s) 1G 1G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10vials 10vials
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2019-04-18 2019-04-18
Estimated end date Unknown 2019-04-29
Actual end date 2019-09-04
Shortage status Resolved Anticipated shortage
Company comments Limited supply . Stock available at some wholesalers/Inventaire disponible chez certains grossistes Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments